OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 37 citing articles:

lncRNA NEAT1: Key player in neurodegenerative diseases
Kun Li, Ziqiang Wang
Ageing Research Reviews (2023) Vol. 86, pp. 101878-101878
Open Access | Times Cited: 70

The role of noncoding RNAs in Parkinson’s disease: biomarkers and associations with pathogenic pathways
Ming‐Che Kuo, Sam Chi-Hao Liu, Ya-Fang Hsu, et al.
Journal of Biomedical Science (2021) Vol. 28, Iss. 1
Open Access | Times Cited: 72

Dysregulated miRNAs as Biomarkers and Therapeutical Targets in Neurodegenerative Diseases
Giulia Gentile, Giovanna Morello, Valentina La Cognata, et al.
Journal of Personalized Medicine (2022) Vol. 12, Iss. 5, pp. 770-770
Open Access | Times Cited: 48

Novel Insights into the Emerging Role of Neat1 and Its Effects Downstream in the Regulation of Inflammation
Yongli Pan, Ting Wang, Zhiqiang Zhao, et al.
Journal of Inflammation Research (2022) Vol. Volume 15, pp. 557-571
Open Access | Times Cited: 39

Non-coding RNAs, a double-edged sword in breast cancer prognosis
Maryam Solaimani, Sahar Hosseinzadeh, Mozhgan Abasi
Cancer Cell International (2025) Vol. 25, Iss. 1
Open Access | Times Cited: 1

The Role of Non-Coding RNAs in the Pathogenesis of Parkinson’s Disease: Recent Advancement
Hanwen Zhang, Longping Yao, Zijian Zheng, et al.
Pharmaceuticals (2022) Vol. 15, Iss. 7, pp. 811-811
Open Access | Times Cited: 29

Neuronal dysfunction and gene modulation by non-coding RNA in Parkinson’s disease and synucleinopathies
Rosaria Meccariello, Gian Carlo Bellenchi, Salvatore Pulcrano, et al.
Frontiers in Cellular Neuroscience (2024) Vol. 17
Open Access | Times Cited: 8

Phosphodiesterase-4 Inhibition in Parkinson’s Disease: Molecular Insights and Therapeutic Potential
Dhritiman Roy, Shivaramakrishnan Balasubramanian, Praveen Thaggikuppe Krishnamurthy, et al.
Cellular and Molecular Neurobiology (2023) Vol. 43, Iss. 6, pp. 2713-2741
Closed Access | Times Cited: 12

Knockdown of long non-coding RNA NEAT1 relieves the inflammatory response of spinal cord injury through targeting miR-211-5p/MAPK1 axis
Qing An, Zipeng Lu, Yi Xie, et al.
Bioengineered (2021) Vol. 12, Iss. 1, pp. 2702-2712
Open Access | Times Cited: 27

Inhibition of lncRNA NEAT1 sensitizes medulloblastoma cells to cisplatin through modulating the miR-23a-3p-glutaminase (GLS) axis
Jingjing Ge, Baohong Wang, Shuai Zhao, et al.
Bioengineered (2022) Vol. 13, Iss. 3, pp. 7670-7682
Open Access | Times Cited: 19

The multifaceted role of phosphodiesterase 4 in tumor: from tumorigenesis to immunotherapy
Huimin Ren, Shaohui Zhang, Peiyuan Li
Frontiers in Immunology (2025) Vol. 16
Open Access

Distinct expression of NEAT1 isoforms in Parkinson’s disease models suggests different roles of the variants during the disease course
Fanni Annamária Boros, Orsolya Horváth, Rita Maszlag-Török, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access

Non-coding RNAs and their bioengineering applications for neurological diseases
Tuhin Das, Tushar Kanti Das, Anne Khodarkovskaya, et al.
Bioengineered (2021) Vol. 12, Iss. 2, pp. 11675-11698
Open Access | Times Cited: 21

Long non-coding RNA SNHG5 regulates ulcerative colitis via microRNA-375 / Janus kinase-2 axis
Hui Li, Ji Xuan, Wei Zhang, et al.
Bioengineered (2021) Vol. 12, Iss. 1, pp. 4150-4158
Open Access | Times Cited: 19

Crosstalk between regulatory non-coding RNAs and oxidative stress in Parkinson’s disease
Hantao Zhang, Xiaoyan Liu, Yi Liu, et al.
Frontiers in Aging Neuroscience (2022) Vol. 14
Open Access | Times Cited: 14

lncRNA NEAT1 promotes autophagy of neurons in mice by impairing miR-107-5p
Dong Li, Yumin Zheng, Xiaoguang Luo
Bioengineered (2022) Vol. 13, Iss. 5, pp. 12261-12274
Open Access | Times Cited: 11

Long Intergenic Noncoding RNAs Affect Biological Pathways Underlying Autoimmune and Neurodegenerative Disorders
Patrycja Plewka, Katarzyna Dorota Raczyńska
Molecular Neurobiology (2022) Vol. 59, Iss. 9, pp. 5785-5808
Open Access | Times Cited: 11

Roflupram alleviates autophagy defects and reduces mutant hSOD1-induced motor neuron damage in cell and mouse models of amyotrophic lateral sclerosis
Di Huo, Weiwei Liang, Di Wang, et al.
Neuropharmacology (2024), pp. 109812-109812
Closed Access | Times Cited: 2

MicroRNA-based interventions in aberrant cell cycle diseases: Therapeutic strategies for cancers, central nervous system disorders and comorbidities
Xiaojuan Tang, Yuan Ren, Wen Zeng, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 177, pp. 116979-116979
Open Access | Times Cited: 2

Expression of lncRNA NEAT1 in endometriosis and its biological functions in ectopic endometrial cells as mediated via miR-124-3p
Donglan Yuan, Dandan Zhu, Boyu Yin, et al.
Genes & Genomics (2022) Vol. 44, Iss. 5, pp. 527-537
Closed Access | Times Cited: 10

Nuclear and Mitochondrial Genome, Epigenome and Gut Microbiome: Emerging Molecular Biomarkers for Parkinson’s Disease
Gleyce Fonseca Cabral, Ana Paula Schaan, Giovanna C. Cavalcante, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 18, pp. 9839-9839
Open Access | Times Cited: 11

The Role of Long Non-coding RNA, Nuclear Enriched Abundant Transcript 1 (NEAT1) in Cancer and Other Pathologies
Miao Zhang, Jianmin Guo, Lifei Liu, et al.
Biochemical Genetics (2021) Vol. 60, Iss. 3, pp. 843-867
Closed Access | Times Cited: 11

Page 1 - Next Page

Scroll to top